📰 5 sources covering this story

'Cornucopia' of bogus medications seized at O’Hare includes erectile dysfunction, weight loss drugs

First covered 3 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

'Cornucopia' of bogus medications seized at O’Hare includes erectile dysfunction, weight loss drugs
'Cornucopia' of bogus medications seized at O’Hare includes erectile dysfunction, weight loss drugs
Customs agents at O’Hare Airport on Tuesday announced the seizure of a massive shipment of “unapproved medications” from China that included erectile dysfunction and weight loss drugs. The shipment destined for Syracuse, New York, was intercepted by a U.S. Customs and Border Protection team at O’Hare, the agency said i
Quartz
Quartz1 days ago
Doctors and the FDA are raising alarms over compounded weight loss drugs
The FDA issued 25 warning letters to telehealth companies last month over misleading claims about compounded versions of drugs like Ozempic
The Hill
The Hill1 days ago
Compounded GLP-1 drugs creating concern among doctors and FDA
They're often cheaper and easier to get than Ozempic, but doctors say compounded GLP-1 drugs come with serious risks.
Indian Express
Indian Express1 days ago
Top endocrinologists call for diet to become standard care with GLP-1 weight loss drugs for Indians
A new consensus by leading Indian endocrinologists recommends structured nutritional counselling for every patient taking GLP-1 weight loss drugs such as semaglutide and tirzepatide to preserve muscle and sustain weight loss. (Representative image)Weight loss drugs like semaglutide and tirzepatide have transformed the
The Rio Times
The Rio Times🏁 first to report3 days ago
South Africa Orders Urgent Recall of Compounded Weight-Loss Drugs
Africa · Southern Key Facts —The recall. SAHPRA ordered a Class I, Type A recall of compounded semaglutide and tirzepatide products made by iDexis/Sentra Pharmacy. —The warning. Prescribers and pharmacists face fines from R25,000 to R75,000 (about US$1,500–US$4,600) and potential loss of licence. —The court case. Novo